Reactome | The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models

Schema > LiteratureReference > Entries

The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models Show undefined attributes

author	[Person:2460047] Zhang, S [Person:9029429] Anjum, R [Person:9702322] Squillace, R [Person:9702317] Nadworny, S [Person:200470] Zhou, T [Person:9702314] Keats, J [Person:9670330] Ning, Y [Person:9702325] Wardwell, SD [Person:5635757] Miller, D [Person:9652188] Song, Y [Person:9702310] Eichinger, L [Person:9702311] Moran, L [Person:9702316] Huang, WS [Person:9702323] Liu, S [Person:9702318] Zou, D [Person:9702319] Wang, Y [Person:9702315] Mohemmad, Q [Person:9702312] Jang, HG [Person:9702321] Ye, E [Person:9702324] Narasimhan, N [Person:9670323] Wang, F [Person:9702308] Miret, J [Person:9695645] Zhu, X [Person:9670322] Clackson, T [Person:9702313] Dalgarno, D [Person:9700349] Shakespeare, WC [Person:9670320] Rivera, VM
created	[InstanceEdit:9702320] Rothfels, Karen, 2020-09-29
dbId	9702309
displayName	The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
journal	Clin. Cancer Res.
pages	5527-5538
pubMedIdentifier	27780853
schemaClass	LiteratureReference
title	The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
url	http://www.ncbi.nlm.nih.gov/pubmed/27780853
volume	22
year	2016

Referrals

(literatureReference)

[Reaction:R-HSA-9700662] Liganded-ALK dimer binds type I ALK-binding TKIs

(author)

© 2026 Reactome

Cite Us!